| |
| |
|
| Insider
Information: |
Landry Robert E |
| Relationship: |
EVP Finance CFO |
| City: |
Tarrytown |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
23,693 |
|
|
Indirect Shares
|
270 |
|
|
| Direct
Value |
$23,762,894 |
|
|
|
Indirect Value
|
$270,797 |
|
|
| Total
Shares |
23,963 |
|
|
| Total
Value |
$24,033,691 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 16.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
EVP Finance CFO |
2024-02-02 |
23,693 |
2024-02-02 |
270 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
158 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2023-12-13 |
4 |
OE |
$378.98 |
$378,980 |
D/D |
1,000 |
22,084 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2023-12-27 |
4 |
OE |
$378.98 |
$284,235 |
D/D |
750 |
22,111 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2023-12-28 |
4 |
OE |
$378.98 |
$322,133 |
D/D |
850 |
22,419 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2024-01-02 |
4 |
OE |
$378.98 |
$246,337 |
D/D |
650 |
22,457 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2024-01-03 |
4 |
OE |
$378.98 |
$416,878 |
D/D |
1,100 |
23,136 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2024-01-04 |
4 |
OE |
$378.98 |
$189,490 |
D/D |
500 |
22,948 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2024-01-12 |
4 |
OE |
$378.98 |
$303,184 |
D/D |
800 |
23,406 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2024-01-17 |
4 |
OE |
$378.98 |
$189,490 |
D/D |
500 |
23,338 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2024-01-23 |
4 |
OE |
$378.98 |
$416,878 |
D/D |
1,100 |
24,084 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2024-01-24 |
4 |
OE |
$378.98 |
$189,490 |
D/D |
500 |
23,808 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2024-01-31 |
4 |
OE |
$378.98 |
$151,592 |
D/D |
400 |
23,856 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2024-02-02 |
4 |
OE |
$378.98 |
$151,592 |
D/D |
400 |
23,974 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2021-08-06 |
4 |
OE |
$381.92 |
$763,840 |
D/D |
2,000 |
27,903 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2021-08-09 |
4 |
OE |
$381.92 |
$1,145,760 |
D/D |
3,000 |
28,903 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-03-17 |
4 |
OE |
$381.92 |
$139,401 |
D/D |
365 |
29,242 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-03-21 |
4 |
OE |
$381.92 |
$152,768 |
D/D |
400 |
29,056 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-04-08 |
4 |
OE |
$381.92 |
$3,090,840 |
D/D |
8,000 |
32,158 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-10-14 |
4 |
OE |
$381.92 |
$572,880 |
D/D |
1,500 |
30,244 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-10-31 |
4 |
OE |
$381.92 |
$763,840 |
D/D |
2,000 |
30,744 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-12-01 |
4 |
OE |
$381.92 |
$954,800 |
D/D |
2,500 |
31,244 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-12-08 |
4 |
OE |
$381.92 |
$1,145,760 |
D/D |
3,000 |
31,744 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2023-02-03 |
4 |
OE |
$381.92 |
$1,145,760 |
D/D |
3,000 |
35,105 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
• – – |
2018-09-10 |
4 |
D |
$395.29 |
$889,798 |
D/D |
(2,251) |
4,848 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-02-13 |
4 |
AS |
$398.63 |
$42,806 |
D/D |
(107) |
24,973 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-07-07 |
4 |
OE |
$399.66 |
$6,555,850 |
D/D |
12,500 |
27,152 |
0 |
- |
|
158 Records found
|
|
Page 2 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
